IL133863A0 - Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis - Google Patents
Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasisInfo
- Publication number
- IL133863A0 IL133863A0 IL13386398A IL13386398A IL133863A0 IL 133863 A0 IL133863 A0 IL 133863A0 IL 13386398 A IL13386398 A IL 13386398A IL 13386398 A IL13386398 A IL 13386398A IL 133863 A0 IL133863 A0 IL 133863A0
- Authority
- IL
- Israel
- Prior art keywords
- drugs
- acid derivatives
- removal promotion
- pain remission
- urinary lithiasis
- Prior art date
Links
- FZBSFRTYISUPFO-UHFFFAOYSA-N 4-amino-2-phenoxybutanoic acid Chemical class NCCC(C(O)=O)OC1=CC=CC=C1 FZBSFRTYISUPFO-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 208000008281 urolithiasis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23323997 | 1997-07-25 | ||
| PCT/JP1998/003163 WO1999005090A1 (fr) | 1997-07-25 | 1998-07-15 | Derives d'acide aminoethylphenoxyacetique et medicaments qui reduisent la douleur et favorisent la suppression des calculs dans la lithiase urinaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL133863A0 true IL133863A0 (en) | 2001-04-30 |
Family
ID=16951956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13386398A IL133863A0 (en) | 1997-07-25 | 1998-07-15 | Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6399660B1 (cs) |
| EP (1) | EP1002791B1 (cs) |
| JP (1) | JP4002391B2 (cs) |
| KR (1) | KR100545473B1 (cs) |
| CN (1) | CN1137877C (cs) |
| AR (1) | AR013241A1 (cs) |
| AT (1) | ATE280146T1 (cs) |
| AU (1) | AU754579B2 (cs) |
| BR (1) | BR9811483B1 (cs) |
| CA (1) | CA2298493C (cs) |
| CO (1) | CO4970779A1 (cs) |
| CZ (1) | CZ300389B6 (cs) |
| DE (1) | DE69827137T2 (cs) |
| ES (1) | ES2231996T3 (cs) |
| HU (1) | HUP0004055A3 (cs) |
| ID (1) | ID24062A (cs) |
| IL (1) | IL133863A0 (cs) |
| MY (1) | MY126743A (cs) |
| NO (1) | NO315422B1 (cs) |
| NZ (1) | NZ502366A (cs) |
| PE (1) | PE99899A1 (cs) |
| PL (1) | PL191864B1 (cs) |
| PT (1) | PT1002791E (cs) |
| RU (1) | RU2196130C2 (cs) |
| SA (1) | SA98190661B1 (cs) |
| TW (1) | TW418184B (cs) |
| WO (1) | WO1999005090A1 (cs) |
| ZA (1) | ZA986580B (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1072583B1 (en) * | 1998-04-14 | 2004-09-01 | Kissei Pharmaceutical Co., Ltd. | 2-methylpropionic acid derivatives and medicinal compositions containing the same |
| MY126489A (en) | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| ATE309978T1 (de) * | 1999-01-21 | 2005-12-15 | Kissei Pharmaceutical | Kristall-polymorphismus von derivaten der aminoethyl-phenoxyessigsäure |
| JP4532119B2 (ja) * | 2002-03-22 | 2010-08-25 | キッセイ薬品工業株式会社 | 腎疾患の予防又は治療剤 |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| WO2005077355A1 (ja) * | 2004-02-12 | 2005-08-25 | Kissei Pharmaceutical Co., Ltd. | 食道の運動障害を伴う疾患の予防または治療用医薬組成物 |
| WO2007004639A1 (ja) * | 2005-07-06 | 2007-01-11 | Daiichi Fine Chemical Co., Ltd. | 光学活性エリスロ-β-アミノアルコールの製法 |
| ZA200801858B (en) * | 2005-08-29 | 2009-07-29 | Kissei Pharmaceutical | Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid |
| EP1769792A1 (de) * | 2005-09-30 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden |
| ES2302447B1 (es) * | 2006-10-20 | 2009-06-12 | Laboratorios Almirall S.A. | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE1994T1 (de) * | 1979-06-16 | 1982-12-15 | Beecham Group Plc | Aethanamin-derivate, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen. |
| IT1256345B (it) * | 1992-08-20 | 1995-12-01 | Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione | |
| US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
| KR19990071800A (ko) * | 1995-11-30 | 1999-09-27 | 간자와 무츠오 | 신규한 요로 결석증의 동통 완해 및 배석 촉진제 |
| AU4320297A (en) * | 1996-09-26 | 1998-04-17 | Kissei Pharmaceutical Co. Ltd. | 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives |
-
1997
- 1997-07-25 ID IDW20000131A patent/ID24062A/id unknown
-
1998
- 1998-07-15 WO PCT/JP1998/003163 patent/WO1999005090A1/ja active IP Right Grant
- 1998-07-15 EP EP98932517A patent/EP1002791B1/en not_active Expired - Lifetime
- 1998-07-15 PT PT98932517T patent/PT1002791E/pt unknown
- 1998-07-15 HU HU0004055A patent/HUP0004055A3/hu unknown
- 1998-07-15 CA CA002298493A patent/CA2298493C/en not_active Expired - Fee Related
- 1998-07-15 JP JP2000504092A patent/JP4002391B2/ja not_active Expired - Fee Related
- 1998-07-15 PL PL338234A patent/PL191864B1/pl not_active IP Right Cessation
- 1998-07-15 IL IL13386398A patent/IL133863A0/xx not_active IP Right Cessation
- 1998-07-15 BR BRPI9811483-2A patent/BR9811483B1/pt not_active IP Right Cessation
- 1998-07-15 AT AT98932517T patent/ATE280146T1/de active
- 1998-07-15 ES ES98932517T patent/ES2231996T3/es not_active Expired - Lifetime
- 1998-07-15 CZ CZ20000272A patent/CZ300389B6/cs not_active IP Right Cessation
- 1998-07-15 NZ NZ502366A patent/NZ502366A/xx not_active IP Right Cessation
- 1998-07-15 DE DE69827137T patent/DE69827137T2/de not_active Expired - Lifetime
- 1998-07-15 RU RU2000101840/04A patent/RU2196130C2/ru not_active IP Right Cessation
- 1998-07-15 KR KR1020007000694A patent/KR100545473B1/ko not_active Expired - Fee Related
- 1998-07-15 AU AU82419/98A patent/AU754579B2/en not_active Ceased
- 1998-07-15 CN CNB988075482A patent/CN1137877C/zh not_active Expired - Fee Related
- 1998-07-16 MY MYPI98003263A patent/MY126743A/en unknown
- 1998-07-20 TW TW087111774A patent/TW418184B/zh not_active IP Right Cessation
- 1998-07-22 PE PE1998000659A patent/PE99899A1/es not_active Application Discontinuation
- 1998-07-22 AR ARP980103575A patent/AR013241A1/es active IP Right Grant
- 1998-07-23 ZA ZA986580A patent/ZA986580B/xx unknown
- 1998-07-23 CO CO98041910A patent/CO4970779A1/es unknown
- 1998-10-19 SA SA98190661A patent/SA98190661B1/ar unknown
-
1999
- 1999-05-21 US US09/463,432 patent/US6399660B1/en not_active Expired - Lifetime
-
2000
- 2000-01-25 NO NO20000371A patent/NO315422B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9610935B (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate | |
| PL307463A1 (en) | Pharmaceutical agent especially for inhibiting osteoporosis and lowering cholesterol level in blood serum | |
| EP1024130A4 (en) | BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE | |
| HUP0001286A3 (en) | Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs | |
| EP1216980A4 (en) | CARBOXYLIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THE SAME | |
| PL331374A1 (en) | Method of selectively obtaining acetic acid and catalyst suitable for use in that method | |
| HUP9902451A3 (en) | Process and device for promotion of regeneration of organized tissues | |
| HUP0100597A3 (en) | Hydroxamic and carboxylic acid derivatives | |
| IL133863A0 (en) | Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis | |
| AU6157899A (en) | Catheter flush solution and method for its use | |
| GB9911071D0 (en) | Hydroxamic and carboxylic acid derivatives | |
| IL131666A0 (en) | Novel carboxylic acid derivatives their preparation and use in treating cancer | |
| HUP0004510A3 (en) | Process for obtaining l-dihydroorotic acid and use thereof | |
| GB2333042B (en) | Colonic delivery of weak acid drugs | |
| HUP0102073A3 (en) | Hydroxamic and carboxylic acid derivatives and medicaments containing them | |
| GB9911075D0 (en) | HYdroxamic and carboxylic acid derivatives | |
| GB9911073D0 (en) | Hydroxamic and carboxylic acid derivatives | |
| AU5319400A (en) | Molecules for disease detection and treatment | |
| AU8236298A (en) | Use of a humic acid-containing substance in medicine | |
| AU5457300A (en) | Surface stabilized microbubbles for use in ultrasound contrast and drug deliveryagents | |
| EP1173185A4 (en) | MEDICAMENT FOR IMPROVING FERTILITY AND FATAL DEVELOPMENT | |
| GB9813932D0 (en) | Hydroxamic and carboxylic acid derivatives | |
| GB9819570D0 (en) | Hydroxamic and carboxylic acid derivatives | |
| GB9819572D0 (en) | Hydroxamic and carboxylic acid derivatives | |
| ZA9810846B (en) | An active hedgehog-protein-mutant a process for its preparation and its use for pharmaceutical purposes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |